NCT04762238

Brief Summary

The carpal tunnel syndrome (CTS) is a common entrapment neuropathy caused by compression of the median nerve at the wrist.Clinically electroneuphysiological assessment is not accessible to all clinicians. In this way ultrasounds (US) is a more accessible and economical tool and many studies have reported that US has high sensitivity and specificity in the diagnosis of CTS.Diacutaneous Fibrolysis (DF) is a physiotherapeutic technique derived from Cyriax deep friction massage principles.DF technique could assist in improving changes in the connective tissues adjacent to the median nerve, especially the thickness of TCL and this could be reflected in a decreasing of TCL. Moreover, the neurophysiological and mechanical effect described by this technique may improve the nerve compression decreasing the CSA of the median nerve. The purpose of this study is to quantify changes in the cross-sectional area of the median nerve in the carpal tunnel and the thickness of transversal carpal ligament measured by US and the changes in the intensity of the numbness and the subjective assessment of clinical change after DF treatment in forearm, wrist and hand area compared to placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

February 10, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2021

Completed
Last Updated

January 18, 2022

Status Verified

January 1, 2022

Enrollment Period

3 months

First QC Date

February 10, 2021

Last Update Submit

January 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Cross sectional area of the median nerve with ultrasonography

    Cross sectional area of the median nerve with ultrasonography at carpal tunnel level

    Baseline (Before the treatment)

  • Cross sectional area of the median nerve with ultrasonography

    Cross sectional area of the median nerve with ultrasonography at carpal tunnel level

    After treatment application, an average of 2 weeks

Secondary Outcomes (5)

  • Intensity of numbness with the Visual Analogue Scale (VAS 1-10cm)

    Baseline (Before the treatment)

  • Intensity of numbness with the Visual Analogue Scale (VAS 1-10cm)

    After treatment application, an average of 2 weeks

  • Thicknesses of transverse carpal ligament with ultrasonography

    Baseline (Before the treatment)

  • Thicknesses of transverse carpal ligament with ultrasonography

    After treatment application, an average of 2 weeks

  • Subjective assessment of clinical change with the Global Rating of Change Scale (GROC Scale)

    After treatment application, an average of 2 weeks

Study Arms (2)

Actual Diacutaneous Fibrolysis

EXPERIMENTAL

Diacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.

Other: Diacutaneous Fibrolysis

Sham Diacutaneous Fibrolysis

SHAM COMPARATOR

Sham Diacutaneous Fibrolysis is applied at a superficial level. A pinch of skin was held with the thumb of the palpatory hand and the tip of the spatula but without effect in the muscle because no penetrate in deep tissue

Other: Diacutaneous Fibrolysis

Interventions

Diacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.

Actual Diacutaneous FibrolysisSham Diacutaneous Fibrolysis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Diagnosed medically with neurophysiological test of carpal tunnel syndrome (low and moderate intensity)

You may not qualify if:

  • Severe carpal tunnel syndrome
  • Previous surgery on the hand
  • hormonal factors: diabetes, thyroids pathologies, pregnant
  • Cervical disfunctions
  • Ulcerations or skins disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sandra Jiménez Jiménez-del-Barrio

Soria, 42004, Spain

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Sandra Jiménez-del-Barrio, PhD

    University of Valladolid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Physiotherapist

Study Record Dates

First Submitted

February 10, 2021

First Posted

February 21, 2021

Study Start

February 10, 2021

Primary Completion

May 20, 2021

Study Completion

July 10, 2021

Last Updated

January 18, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations